Roche Holding AG (RHHBY.PK), Tuesday announced the launch of the new cobas 6800/8800 systems version 2.0 and software version 2.0.1, supporting a more streamlined diagnostics experience.
The update aims to improve the efficiency of laboratories by optimizing resources, reducing downtime, consolidating test menus and increasing throughput.
The company noted that the updates and improvements can be made to existing 6800/8800 systems through the software upgrade.
"This update is significant because it not only allows for new innovation in PCR-testing technology and more choices in omni-channel testing, but it also addresses some key improvements that customers have told us are high priorities for them," said Brad Moore, President and CEO, Roche Diagnostics North America.
Roche's stock closed at $51.22, up 2.40 percent on the OTC Markets.
For comments and feedback contact: editorial@rttnews.com
Health News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.